Biotech Co. Vows Corporate Reforms To End Securities Suits
By Brian Dowling ( January 22, 2021, 11:59 AM EST) -- Shareholders behind litigation in three states accusing Acer Therapeutics Inc. of misrepresenting the potential for a U.S. Food and Drug Administration approval settled their lawsuits against the Massachusetts-based company in exchange for a slate of corporate reforms designed to improve its public disclosures, according to a Thursday filing....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.